WO2023274301A1 - 检测核酸的芯片装置和仪器及其应用 - Google Patents
检测核酸的芯片装置和仪器及其应用 Download PDFInfo
- Publication number
- WO2023274301A1 WO2023274301A1 PCT/CN2022/102391 CN2022102391W WO2023274301A1 WO 2023274301 A1 WO2023274301 A1 WO 2023274301A1 CN 2022102391 W CN2022102391 W CN 2022102391W WO 2023274301 A1 WO2023274301 A1 WO 2023274301A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- piston
- valve
- cavity
- sample
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 447
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 446
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 446
- 238000001514 detection method Methods 0.000 title claims abstract description 85
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 243
- 230000003321 amplification Effects 0.000 claims abstract description 241
- 238000000605 extraction Methods 0.000 claims abstract description 104
- 239000012530 fluid Substances 0.000 claims abstract description 83
- 238000004140 cleaning Methods 0.000 claims abstract description 54
- 238000004891 communication Methods 0.000 claims abstract description 47
- 230000009089 cytolysis Effects 0.000 claims abstract description 46
- 238000009739 binding Methods 0.000 claims abstract description 43
- 239000000758 substrate Substances 0.000 claims abstract description 27
- 238000010828 elution Methods 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 26
- 238000012123 point-of-care testing Methods 0.000 claims abstract description 6
- 239000000523 sample Substances 0.000 claims description 266
- 239000003153 chemical reaction reagent Substances 0.000 claims description 132
- 238000002156 mixing Methods 0.000 claims description 131
- 238000006243 chemical reaction Methods 0.000 claims description 128
- 238000005070 sampling Methods 0.000 claims description 98
- 230000033001 locomotion Effects 0.000 claims description 90
- 238000003860 storage Methods 0.000 claims description 56
- 239000000243 solution Substances 0.000 claims description 44
- 230000002934 lysing effect Effects 0.000 claims description 43
- 238000005336 cracking Methods 0.000 claims description 33
- 238000011144 upstream manufacturing Methods 0.000 claims description 31
- 230000007246 mechanism Effects 0.000 claims description 30
- 230000000903 blocking effect Effects 0.000 claims description 27
- 239000007788 liquid Substances 0.000 claims description 25
- 230000001276 controlling effect Effects 0.000 claims description 18
- 238000010790 dilution Methods 0.000 claims description 17
- 239000012895 dilution Substances 0.000 claims description 17
- 239000012488 sample solution Substances 0.000 claims description 15
- 239000002480 mineral oil Substances 0.000 claims description 8
- 235000010446 mineral oil Nutrition 0.000 claims description 8
- 238000004458 analytical method Methods 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- 230000001105 regulatory effect Effects 0.000 claims description 6
- 238000001917 fluorescence detection Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 4
- 239000005662 Paraffin oil Substances 0.000 claims description 3
- 239000012445 acidic reagent Substances 0.000 claims description 3
- 239000013013 elastic material Substances 0.000 claims description 3
- 239000011324 bead Substances 0.000 description 19
- 239000000463 material Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 238000003752 polymerase chain reaction Methods 0.000 description 10
- 238000007865 diluting Methods 0.000 description 9
- 239000000696 magnetic material Substances 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 238000011068 loading method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 238000007403 mPCR Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000856 Lyases Proteins 0.000 description 4
- 102000004317 Lyases Human genes 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000011901 isothermal amplification Methods 0.000 description 4
- 238000004020 luminiscence type Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 208000035473 Communicable disease Diseases 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000012669 liquid formulation Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000709661 Enterovirus Species 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000008383 Wilms tumor Diseases 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000337692 Bunia Species 0.000 description 1
- 235000013049 Bunias Nutrition 0.000 description 1
- 241000186221 Cellulosimicrobium cellulans Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 241000223203 Coccidioides Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
- 101001018100 Homo sapiens Lysozyme C Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 108090000988 Lysostaphin Proteins 0.000 description 1
- 108010053229 Lysyl endopeptidase Proteins 0.000 description 1
- 241001115401 Marburgvirus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000032236 Predisposition to disease Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241001361634 Rhizoctonia Species 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 241000192023 Sarcina Species 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 241000589884 Treponema pallidum Species 0.000 description 1
- 241000223260 Trichoderma harzianum Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000907316 Zika virus Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- -1 etc. Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000009347 mechanical transmission Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 108010009719 mutanolysin Proteins 0.000 description 1
- 201000008026 nephroblastoma Diseases 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000005395 radioluminescence Methods 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 238000005393 sonoluminescence Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 108010075210 streptolysin O Proteins 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 108010052441 tetanolysin Proteins 0.000 description 1
- 238000000904 thermoluminescence Methods 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 244000052613 viral pathogen Species 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502738—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by integrated valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/52—Containers specially adapted for storing or dispensing a reagent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/36—Apparatus for enzymology or microbiology including condition or time responsive control, e.g. automatically controlled fermentors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/36—Apparatus for enzymology or microbiology including condition or time responsive control, e.g. automatically controlled fermentors
- C12M1/38—Temperature-responsive control
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16K—VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
- F16K99/00—Subject matter not provided for in other groups of this subclass
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0621—Control of the sequence of chambers filled or emptied
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0829—Multi-well plates; Microtitration plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/087—Multiple sequential chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0478—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure pistons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/32—Mycobacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/37—Proteus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/44—Staphylococcus
- C12R2001/445—Staphylococcus aureus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/63—Vibrio
Definitions
- the invention relates to the field of biotechnology and equipment application, in particular to a chip device and instrument for detecting nucleic acid in a sample, and its application in biological sample detection.
- nucleic acid The detection of nucleic acid is the core of clinical trials, identification of pathogenic microorganisms and many other fields.
- Various diseases such as cancer, microbial infection and genetic markers can be detected through nucleic acid extraction, amplification and detection analysis.
- PCR and real-time PCR is an effective method for exponentially amplifying and detecting genes.
- the genetic testing market using PCR/real-time PCR devices is rapidly expanding in the genetic testing of infectious diseases such as viral, sexually transmitted diseases, and influenza.
- infectious diseases such as viral, sexually transmitted diseases, and influenza.
- the role of genetic testing in cancer treatment has become apparent.
- automation, especially small automation, of applications employing PCR and RT-PCR is not easy.
- Multiplex PCR which simultaneously amplifies multiple gene regions by using multiple pairs of primers in one PCR system, has attracted attention.
- Real-time multiplex PCR developed from multiplex PCR, aims to detect and quantify multiple different genes of interest independently without being affected by other genes of interest (crosstalk) and without compromising sensitivity.
- crosstalk genes of interest
- the power source provides power for the movement of the microfluidics within the carrier (such as chip, pipe, etc.).
- the carrier such as chip, pipe, etc.
- Currently commonly used methods include injection, centrifugal, pneumatic and so on. Valves can control the movement behavior of microfluidics in the carrier. Due to the small scale of microfluidics, it is very difficult to construct valves with sufficient precision, sufficient quantity and convenient opening and closing inside the carrier. For laboratories studying microfluidics, syringe pumps are the most commonly used power source.
- the carrier By sucking the fluid into the syringe, connecting the syringe to the inlet of the microfluidic carrier (hereinafter referred to as the carrier), and then using a high-precision syringe pump to push the syringe, the injection of the microfluid into the carrier is realized.
- the carrier By sucking the fluid into the syringe, connecting the syringe to the inlet of the microfluidic carrier (hereinafter referred to as the carrier), and then using a high-precision syringe pump to push the syringe, the injection of the microfluid into the carrier is realized.
- this kind of operation has many steps, it is difficult to switch fluid samples, and it is difficult to realize automatic sampling of microfluidics.
- the field also needs high-speed real-time, small and convenient nucleic acid amplification and detection devices and instruments, especially chip devices and instruments suitable for on-site rapid inspection (point-of-care testing, POCT).
- POCT point-of-care testing
- the invention provides a chip device for detecting nucleic acid in a sample, which has a substrate and a piston-type container, and the piston-type container communicates with each other through a microfluidic channel, wherein the piston-type container includes a cavity and a The piston in the body has an opening in communication with the microfluidic channel at the bottom of the cavity.
- the chip device further has a piston valve located between the containers for controlling fluid communication between the interconnected containers, and the piston valve includes a valve cavity and a valve located in the valve cavity
- the piston includes a valve cavity and a valve located in the valve cavity
- the valve piston can move to the bottom of the cavity and cover the openings, blocking the communication between the cavity and the fluid channel, thereby blocking the flow through the
- the fluid communication between the containers connected by the fluid channel preferably, the fluid channel communicates with the opening at the bottom of the cavity through an upward flow channel from the bottom of the cavity.
- the chip device includes one or a combination or all of the following modules:
- the sample cracking and nucleic acid extraction module can be used to perform cracking reaction and/or nucleic acid extraction reaction on the sample, and obtain purified nucleic acid from the sample;
- the sample cracking and extraction module has a sample cracking module and/or nucleic acid extraction module, optionally Yes, the nucleic acid extraction module includes a nucleic acid binding unit, a nucleic acid cleaning unit and a nucleic acid eluting unit;
- the nucleic acid amplification module is used for distributing nucleic acid samples to multiple amplification zone containers (such as amplification reaction chambers) and amplifying and/or detecting nucleic acid molecules; the nucleic acid amplification module includes multiple amplification zone modules and any The selected preamplifier module.
- the chip device includes the following modules:
- the sample cracking and nucleic acid extraction module can be used to perform cracking reaction and/or nucleic acid extraction reaction on the sample, and obtain purified nucleic acid from the sample;
- the sample cracking and extraction module has a sample cracking module and/or nucleic acid extraction module, optionally Yes, the nucleic acid extraction module includes a nucleic acid binding unit, a nucleic acid cleaning unit and a nucleic acid eluting unit;
- the nucleic acid amplification module is used for distributing nucleic acid samples to multiple amplification zone containers (such as amplification reaction chambers) and amplifying and/or detecting nucleic acid molecules; the nucleic acid amplification module includes multiple amplification zone modules and any The selected preamplifier module.
- the sample receiving module in the chip device includes a sampling cavity, which is a piston container, including a cavity and a piston located in the cavity.
- the sample receiving module includes a sample loading chamber and a sampling chamber.
- it also includes a sampling cavity valve between the sampling cavity and the sampling cavity, for example, it is a piston valve, including a valve cavity and a valve piston positioned in the valve cavity, and the bottom of the valve cavity has a The two openings connected to the sampling cavity, the piston can move to the bottom of the cavity and cover the openings, blocking the fluid communication between the sampling cavity and the sampling cavity.
- the sample lysing and extraction module in the chip device includes a first mixing chamber and a second mixing chamber
- the first mixing chamber and the second mixing chamber are piston-type containers, including a chamber Body and piston located in the cavity.
- a mixing chamber valve between the first mixing chamber and the second mixing chamber for example, it is a piston valve, including a valve chamber and a valve piston located in the valve chamber, and the bottom of the valve chamber is respectively connected to the first mixing chamber.
- Two openings communicating between the mixing chamber and the second mixing chamber, the piston can move to the bottom of the chamber and cover the openings, blocking the fluid communication between the first mixing chamber and the second mixing chamber.
- a sampling valve between the first mixing chamber and the upstream sample receiving module (such as the sampling chamber therein), which is, for example, a piston valve, including a valve cavity and a valve cavity located in the valve cavity.
- the valve piston the bottom of the valve cavity has two openings respectively communicated with the sampling chamber and the first mixing chamber, the piston can move to the bottom of the cavity and cover the opening, blocking the sampling chamber and the first mixing chamber fluid communication between them.
- the sample lysis module of the sample lysis and nucleic acid extraction module in the chip device includes a lysis reagent storage chamber for containing the lysis reagent, which is a piston container, including a cavity and a the piston.
- the sample lysing module also includes a lysing reagent valve between the lysing reagent storage chamber and the chamber for sample lysing, the lysing reagent valve is, for example, a piston valve, including a valve chamber and a valve chamber located in the valve chamber.
- the valve piston has two openings at the bottom of the valve chamber which are connected with the lysis reagent storage chamber and the sample lysis chamber respectively. The piston can move to the bottom of the chamber and cover the openings, blocking the lysis reagent storage chamber and the sample lysis chamber. Fluid communication between the lysed chambers.
- the sample lysis and nucleic acid extraction module in the chip device has one or more of a binding unit, a cleaning unit, and an eluting unit, which respectively have a nucleic acid binding reagent, a nucleic acid Nucleic acid binding reagent storage cavity, nucleic acid cleaning reagent storage cavity and nucleic acid elution reagent storage cavity for cleaning reagent and nucleic acid eluting reagent.
- the nucleic acid binding reagent storage chamber, the nucleic acid cleaning reagent storage chamber and the nucleic acid elution reagent storage chamber are piston-type containers, including a cavity body and a piston located in the cavity.
- the nucleic acid binding reagent storage chamber, the nucleic acid cleaning reagent storage chamber and the nucleic acid eluting reagent storage chamber are respectively connected with the nucleic acid binding reagent valve, nucleic acid cleaning reagent valve or nucleic acid eluting reagent valve for nucleic acid binding, nucleic acid reagent or nucleic acid
- the chambers for the elution reaction are connected.
- the nucleic acid binding reagent valve, nucleic acid cleaning reagent valve or nucleic acid eluting reagent valve is, for example, a piston valve.
- the cavity for sample lysis and the cavity for nucleic acid binding, nucleic acid reagent and/or nucleic acid elution reaction in the chip device is the first mixing cavity and/or the second mixing cavity. mixing chamber.
- the nucleic acid extraction module in the chip device also includes a water adding chamber, which is connected to the lysing reagent storage chamber, the nucleic acid binding reagent storage chamber, the nucleic acid cleaning reagent storage chamber and the nucleic acid elution reagent storage chamber through the flow channel.
- a water adding chamber which is connected to the lysing reagent storage chamber, the nucleic acid binding reagent storage chamber, the nucleic acid cleaning reagent storage chamber and the nucleic acid elution reagent storage chamber through the flow channel.
- One or more of the cavities are connected.
- a valve between one or more of the water adding chamber and the lysing reagent storage chamber, the nucleic acid binding reagent storage chamber, the nucleic acid cleaning reagent storage chamber and the nucleic acid elution reagent storage chamber is also included, the valve is, for example, a piston valve .
- the lysing reagent storage chamber and/or the nucleic acid binding reagent storage chamber in the chip device is the first mixing chamber and/or the second mixing chamber.
- the sample lysis and extraction module in the chip device further includes a chamber for the sample to be amplified, which is a piston container, including a chamber and a piston located in the chamber, for containing the lysed and Extracted nucleic acid solution samples.
- a piston valve upstream of the sample cavity to be amplified which includes a valve cavity and a valve piston located in the valve cavity, and the bottom of the valve cavity is respectively connected to the upstream module or unit and the downstream amplification module.
- Two openings, the pistons are movable to the bottom of the chamber and cover said openings, blocking fluid communication between the upstream module or unit and the downstream amplification module.
- the sample lysis and extraction module in the chip device further includes a dilution chamber.
- a dilution valve such as a piston container, between the dilution chamber and its upstream module or unit (eg, the second mixing chamber).
- the sample lysis and extraction module in the chip device further includes a filter unit.
- the filter unit is a filter chamber, which is a piston-type container with a piston in the cavity, and two openings at the bottom of the cavity that communicate with the flow channel, and the flow channel is respectively connected to the upstream
- the diluting chamber is connected with the sample chamber to be amplified downstream, and there is a filter for filtering unwanted substances (such as cells, cell fragments or large protein molecules, etc.) in the nucleic acid extraction solution between the bottom of the chamber and the piston.
- the nucleic acid amplification module has one or more multiple amplification region units.
- the multiple amplification area unit includes a plurality of amplification reaction chambers (set in the bottom plate) for performing nucleic acid amplification reactions, and the nucleic acid sample solution from the sample lysis and extraction module is distributed to each of the amplification reaction chambers through a microfluidic channel. Increased reaction chamber.
- between the multiple amplification area unit and the upstream sample lysing and extraction module (such as between the multiple amplification area unit and the upstream sample chamber to be amplified Between) has a piston valve, the valve cavity has a piston, and the bottom of the valve cavity has an opening that communicates with the flow channel that communicates with the upstream sample cavity to be amplified, and an opening that communicates with the downstream amplification region unit.
- the multiple amplification reaction chambers of the multiple amplification zone unit are distributed along the circumference.
- a multiple amplification sampling valve above it which is a piston valve, with a piston in the valve cavity, and an opening at the bottom of the valve cavity that communicates with the flow channel of the upstream sample cavity to be amplified, and a plurality of openings respectively communicating with each of the plurality of amplification reaction chambers below.
- the multiple amplification reaction chambers of the multiple amplification zone unit are arranged in an array.
- each amplification reaction chamber communicates with the main channel of the amplification zone unit through a branch flow channel, and the main channel of the multiple amplification zone unit communicates with the upstream sample lysis and extraction module.
- the chip device there is a piston valve between the multiple amplification region unit and the upstream sample lysing and extraction module, a piston in the valve cavity, and a valve at the bottom of the valve cavity.
- the opening communicates with the flow channel of the upstream sample cavity to be amplified, and the opening communicates with the main channel of the downstream amplification zone unit.
- the nucleic acid amplification module has an inert liquid module for storing and providing an inert liquid (such as mineral oil or paraffin oil) for sealing the amplification reaction chamber and the flow channel interface .
- the inert liquid module has an oil filling cavity.
- the inert liquid module also includes a refueling valve between the refueling chamber and the multiple amplification zone unit, which is, for example, a piston valve, with a piston in the valve chamber, and a flow channel connected to the refueling chamber at the bottom of the valve chamber. The opening communicating with the channel, and the opening communicating with the amplification region unit.
- the nucleic acid amplification module further has a pre-amplification area unit arranged upstream of the multiple amplification area unit for performing the first round of amplification on nucleic acid molecules. expansion, such as nested amplification.
- the pre-amplification unit has a nested amplification cavity, for example, it is a cylindrical cavity arranged in the bottom plate, which has a sample lysing and extraction module and a The downstream reamplification zone unit is connected to the flow channel.
- the amplification reaction chambers of the amplification reaction unit are isolated by materials that completely absorb or substantially completely absorb signals generated by the amplification reaction.
- the bottom of each amplification reaction chamber of the amplification reaction unit is prepared or sealed with a material that does not absorb at all or substantially does not absorb signals generated by the amplification reaction.
- the piston valve has a piston movement control member disposed above the valve piston, for controlling the up and down movement of the valve piston in the cavity.
- the cavity wall of the valve cavity of the piston valve has internal threads.
- the piston movement control member has an external thread, which forms a thread pair with the internal thread of the cavity wall, and the piston movement control member rotates along the thread to move in the cavity, Movement of the piston within the cavity is controlled.
- the piston movement control member has a cavity suitable for inserting a control rod, and the cross section of the cavity is a shape adapted to the control rod.
- the bottom of the valve piston of the piston valve mechanism has a piston support body, and the piston support body is a protrusion at the bottom of the piston, which is made of elastic material.
- the cross-sectional diameter of the piston container or piston valve is about 0.5mm-25mm, preferably about 1-20mm, more preferably about 3-15mm.
- the present invention also provides an instrument for detecting nucleic acid in a sample, especially a POCT instrument, which includes the aforementioned chip device provided by the present invention.
- the chip device has a substrate and a piston container, and the piston container communicates with the microfluidic channel, wherein the piston container includes a cavity and a piston located in the cavity, and the bottom of the cavity has a The opening of channel communication;
- the chip device also has a piston valve located between the containers, used to control the fluid communication between the interconnected containers, the piston valve includes a valve cavity and a valve piston located in the valve cavity, the valve
- the bottom of the cavity has two or more openings communicating with the flow channel, the valve piston can move to the bottom of the cavity and cover the openings, blocking the communication between the cavity and the fluid channel, thereby blocking the connection through the fluid channel fluid communication between the vessels,
- the chip device includes:
- the sample cracking and nucleic acid extraction module can be used to perform cracking reaction and/or nucleic acid extraction reaction on the sample, and obtain purified nucleic acid from the sample;
- the sample cracking and extraction module has a sample cracking module and/or nucleic acid extraction module, optionally Yes, the nucleic acid extraction module includes a nucleic acid binding unit, a nucleic acid cleaning unit and a nucleic acid eluting unit;
- the nucleic acid amplification module is used for distributing nucleic acid samples to multiple amplification zone containers (such as amplification reaction chambers) and amplifying and/or detecting nucleic acid molecules; the nucleic acid amplification module includes multiple amplification zone modules and any The selected preamplifier module.
- the instrument has a chip device receiving and movement control system for receiving the above chip device and transferring it to a designated position in the instrument to perform various processes on the chip.
- the instrument has a magnet and a system for controlling the movement of the magnet, and is used for purifying nucleic acid in a sample using a magnetic bead method.
- the nucleic acid is bound by contacting the nucleic acid-binding magnetic material and/or binding solution with the sample that has been lysed, thereby allowing the nucleic acid to bind to the magnetic material.
- the complex formed after the nucleic acid is combined with the magnetic material can controllably move, stir or precipitate in the container under the action of a magnetic field, so as to achieve the purposes of nucleic acid binding, nucleic acid cleaning and nucleic acid elution.
- the instrument has a control mechanism for regulating the movement of a piston motion control in the piston valve.
- the control mechanism includes a control rod and a control rod movement mechanism, the control rod can rotate or move up and down, wherein the control rod movement mechanism includes a component for controlling the control rod up and down movement and rotation, Such as motors.
- the instrument has a signal detection module for detecting nucleic acid amplification products, such as a fluorescence detection system.
- the instrument has a temperature control system for the nucleic acid amplification region of the chip.
- the instrument has a nucleic acid amplification result analysis and/or output system.
- a method for detecting nucleic acid in a sample using the chip device or instrument of the present invention is provided.
- the detection method comprises the following steps:
- the chip device has a substrate and a piston container, and the piston container communicates with each other through a microfluidic channel, wherein the piston container includes a cavity and a The piston in the body, the bottom of the cavity has an opening communicating with the microfluidic channel, and the chip device also has a piston valve located between the containers for controlling the fluid communication between the interconnected containers, the piston valve includes The valve cavity and the valve piston located in the valve cavity, the bottom of the valve cavity has two or more openings communicating with the flow channel, the valve piston can move to the bottom of the cavity and cover the openings, blocking the cavity and the fluid channel communication, thereby blocking the fluid communication between the containers connected through the fluid channel (the fluid channel communicates with the opening at the bottom of the cavity through the upward flow channel from below the cavity).
- the chip arrangement may include:
- the sample cracking and nucleic acid extraction module can be used to perform cracking reaction and/or nucleic acid extraction reaction on the sample, and obtain purified nucleic acid from the sample;
- the sample cracking and extraction module has a sample cracking module and/or nucleic acid extraction module, optionally Yes, the nucleic acid extraction module includes a nucleic acid binding unit, a nucleic acid cleaning unit and a nucleic acid eluting unit;
- the nucleic acid amplification module is used for distributing nucleic acid samples to multiple amplification zone containers (such as amplification reaction chambers) and amplifying and/or detecting nucleic acid molecules; the nucleic acid amplification module includes multiple amplification zone modules and any The selected preamplifier module.
- the apparatus optionally includes:
- Chip device receiving and motion control system
- a control mechanism for regulating the movement of the piston motion control member in the piston valve includes a control rod and a control rod kinematic mechanism, the control rod can be rotated or moved up and down, wherein the control rod kinematic mechanism includes control of the Parts that control levers that move up and down and rotate, such as motors;
- a signal detection module for detecting nucleic acid amplification products such as a fluorescence detection system
- the method optionally includes the steps of:
- the nucleic acid amplification module is used for distributing nucleic acid samples to multiple amplification zone containers and performing amplification and/or detection on nucleic acid molecules.
- the diagnostic instrument is used for identification of infection source, genetic disease, cancer detection or gene variation detection.
- the diagnostic instrument is used for the detection of the following pathogens: coronavirus, influenza virus, enterovirus, hepatitis B virus, hepatitis C virus, Ebola virus, Marburg virus, SARS virus, Zika virus , Bunia virus, rhinovirus, respiratory nucleocytosis virus, cholera virus and other viral pathogens, or Mycobacterium tuberculosis, Escherichia coli, Acinetobacter baumannii, Diplococcus pneumoniae, Streptococcus lactis, Sarcina urea, Staphylococcus aureus, Bacillus subtilis, Bacillus anthracis, Bacillus subtilis, Streptococcus, Proteus, Vibrio cholerae, Treponema pallidum and other bacterial pathogens.
- pathogens coronavirus, influenza virus, enterovirus, hepatitis B virus, hepatitis C virus, Ebola virus, Marburg virus, SARS virus, Zi
- the diagnostic instrument is used for the detection of the following cancers: leukemia, Hodgkin's disease, Wilm's tumor (Wilms tumor), melanoma, retinoblastoma, gastric cancer, liver cancer, lung cancer , Esophageal cancer, cervical cancer, breast cancer, colon cancer, rectal cancer, nasopharyngeal cancer, ovarian cancer, kidney cancer, bladder cancer, thyroid cancer, skin cancer, etc.
- Fig. 1 is a stereoscopic perspective view of an exemplary chip device provided by the present invention for nucleic acid detection in a sample.
- FIG. 2 is another perspective view of the exemplary chip device for nucleic acid detection in a sample shown in FIG. 1 . Compared with FIG. 1 , FIG. 2 does not show the internal thread on the cavity wall of some piston containers or piston valves in the chip device and the piston movement control parts in the cavity of the piston valve.
- FIG. 3 is a schematic top plan view of the structure of the exemplary chip device for detecting nucleic acid in a sample shown in FIG. 1 and the communication relationship of its flow channels.
- FIG. 4 is a schematic diagram of the structure and working mode of an exemplary piston valve and piston motion control mechanism in the chip device for nucleic acid detection in samples provided by the present invention.
- FIG. 4( a ) is a schematic cross-sectional view of the structure of the exemplary piston valve.
- Figure 4(b) and (c) are schematic diagrams of the working mode of the exemplary piston valve.
- Fig. 4(b) shows an exemplary working mode of controlling the downward movement of the piston
- Fig. 4(c) shows an exemplary working mode of controlling the upward movement of the piston.
- Fig. 5 is a perspective view of yet another exemplary chip device used in the detection of nucleic acid in a sample provided by the present invention.
- the figure does not show the internal thread on the cavity wall of some piston containers or piston valves in the chip device provided by the present invention and the piston movement control parts in the cavity of the piston valve.
- FIG. 6 is another perspective view of the exemplary chip device for nucleic acid detection in a sample shown in FIG. 5 .
- the figure does not show the piston in the piston container or the piston valve in the chip device provided by the present invention.
- FIG. 7 is a schematic diagram of the top-view structure of the exemplary chip device for detecting nucleic acid in a sample shown in FIG. 5 and the communication relationship of its flow channels.
- the invention provides a chip device for nucleic acid detection in samples.
- the chip device is usually used to extract and amplify nucleic acid in a sample and detect its presence and amount.
- Fig. 1 is a stereoscopic perspective view of an exemplary chip device provided by the present invention for nucleic acid detection in a sample.
- the chip device provided by the present invention has a substrate 1 and a container area 2 perpendicular to the substrate, a columnar container 3 arranged in parallel is arranged in the container area, and a micro flow channel 4 is arranged in the substrate below the container area,
- the cavity bottom of the columnar container has an opening 5 communicating with the microfluidic channel, and fluid communication between the columnar containers can be realized through the microfluidic channel.
- Piston containers are used to contain a sample or formulation (solid or liquid formulation), which resides in the space between the piston and the bottom of the chamber.
- the bottom of the cavity has an opening communicating with the fluid channel, and the solution is transferred between the containers through the micro flow channel.
- the columnar container also includes a piston valve (such as the piston valve 8 in Fig. 1) for controlling fluid communication between the interconnected containers.
- the piston can move to the bottom of the cavity of the piston valve and cover the opening, blocking the communication between the cavity and the microfluidic channel, thereby blocking the upper channel connected by the fluid channel Fluid communication between downstream vessels.
- the microfluidic channel communicates with the opening at the bottom of the cavity from below the cavity of the piston container or piston valve through an upward channel.
- the chip device provided by the present invention is usually used for temperature-controlled amplification reaction of nucleic acid, and the temperature-controlled amplification reaction is usually carried out in multiple reaction chambers 9 arranged in the substrate.
- the chip device provided by the invention is used for detecting the presence and quantity of nucleic acid in a sample after extraction and amplification.
- the chip device provided by the present invention may include one or more of the following modules:
- a sample receiving module for receiving, dispensing, and holding an appropriate amount of sample for testing
- Sample lysis and nucleic acid extraction module The module is used to accommodate lysis and nucleic acid extraction reagents, perform lysis reaction and/or nucleic acid extraction reaction on the sample, and obtain purified nucleic acid from the sample for the next step of nucleic acid amplification reaction.
- the sample lysis and extraction module may include a sample lysis module for accommodating lysis reagents and performing a lysis reaction on the sample, and may include a nucleic acid extraction module that may include a nucleic acid binding unit, a nucleic acid cleaning unit, and a nucleic acid elution unit , which are respectively used to accommodate nucleic acid binding reagents, nucleic acid cleaning reagents and nucleic acid elution reagents, and perform reactions such as nucleic acid binding, nucleic acid reagents, and nucleic acid elution respectively;
- the nucleic acid amplification module is used for distributing the nucleic acid extracted from the sample to the nucleic acid amplification reaction chamber and amplifying the nucleic acid molecule, especially performing nucleic acid multiple amplification in multiple nucleic acid amplification reaction chambers.
- a first round of nucleic acid amplification can also be performed upstream of the multiple nucleic acid amplification, and the first round of nucleic acid amplification is, for example, nested amplification.
- the nucleic acid amplification module may include a multiple amplification region module and an optional pre-amplification region module.
- the containers used to accommodate solid or liquid preparations or react in each module of the chip device provided by the present invention can be piston containers, and the interconnected containers are connected through fluid channels arranged in the lower substrate, so
- the piston-type container includes a cavity and a piston located in the cavity, the bottom of the cavity has an opening communicating with the fluid channel, the solid or liquid preparation can be accommodated in the space between the piston and the bottom of the cavity, and the solution can pass through the microchannel in the transfer between containers.
- piston valves are provided between the interconnected containers.
- the piston valve includes a valve cavity and a valve piston located in the valve cavity, and the bottom of the valve cavity has two or more openings communicating with the flow channel.
- the fluid channel communicates with the opening at the bottom of the cavity from below the cavity through an upward flow channel.
- the opening is not located on the side wall of the cavity of the piston valve.
- a piston is movable to the bottom of the cavity and covers the opening, blocking communication of the cavity with the fluid passage, thereby blocking fluid communication between containers connected by the fluid passage.
- Nucleic acid samples for use in the methods described herein may be from any source.
- a sample may be biological material isolated from its natural environment and comprising polynucleotides.
- a sample may consist of a purified or isolated polynucleotide, or may comprise a biological sample such as a tissue sample, a biological fluid sample or a cell sample comprising the polynucleotide.
- Biological fluids include blood, plasma, sputum, urine, cerebrospinal fluid, lavage fluid samples as non-limiting examples.
- Nucleic acid samples may be of plant, animal, bacterial or viral origin.
- Samples may be obtained from various sources, including but not limited to, from different individuals, different developmental stages of the same or different individuals, different diseased individuals, normal individuals, different disease stages of the same or different individuals, individuals undergoing different disease treatments, in Samples of individuals with different environmental factors, or individuals with predisposition to disease, or individuals exposed to infectious disease agents.
- unit as used herein is intended to denote an element or combination of elements configured to operate together to perform one or more functions or produce one or more desired results, wherein each element may have a separate , distinct and/or independent functions. It will be understood that each element within a unit need not be directly connected to each other element.
- module used herein is used to denote a unit or a combination of units configured to operate together to realize the functions of one or more subsystems of the device of the present invention. It should be understood that each unit within a module need not be directly connected to each other unit.
- FIG. 1 is a stereoscopic perspective view of an exemplary chip device provided by the present invention for nucleic acid detection in a sample.
- FIG. 2 is another perspective view of the exemplary chip device for nucleic acid detection in a sample shown in FIG. 1 . Compared with FIG. 1 , FIG. 2 does not show the internal thread on the cavity wall of some piston containers or piston valves in the chip device provided by the present invention and the piston movement control parts in the cavity of the piston valve.
- FIG. 3 is a schematic top plan view of the structure of the exemplary chip device for detecting nucleic acid in a sample shown in FIG. 1 and the communication relationship of its flow channels.
- the chip device for detecting nucleic acid in a sample provided by the present invention includes a substrate 1 and a container area 2 perpendicular to the substrate, and a plurality of cylindrical cavities 3 are arranged in the container area 2 .
- the cylindrical cavity is bounded by the walls of the container area perpendicular to the bottom plate, and the bottom has an opening 5 communicating with a fluid channel 4 provided in the bottom plate.
- the plurality of cylindrical cavities communicate with each other through fluid channels 4 provided in the bottom plate.
- the fluid channel is located below the cavity, and communicates with the opening at the bottom of the cavity through an upward flow channel.
- the base plate and container region are made of rigid material. Such materials include, but are not limited to, silica, silicon, quartz, glass, or polymeric materials (eg, PDMS, plastic, etc.).
- the fluid channel provided in the substrate is generally a microfluidic channel, the size of which is on the order of millimeters, for example, the width of the cross-section of the channel is about 0.1-5 mm.
- the terms "fluidic channel”, “microfluidic channel” and “microfluidic channel” are used interchangeably.
- the cross section of the flow channel of the fluid channel can be in various shapes, including ellipse, rectangle, square, circle and so on. In one aspect of the present invention, the cross-section of the flow channel has a width of about 0.1-5 mm, preferably about 0.2 mm-2 mm.
- the wall of the cylindrical cavity and the bottom plate can be made of materials that completely absorb or substantially absorb the target signal (such as fluorescence).
- the bottom of the amplification reaction area (usually a cavity) is prepared or sealed with a material that does not absorb at all or substantially does not absorb the signal to be detected.
- the signal detection module disposed in the chip or an external detection system can detect the fluorescent signals generated in each amplification reaction region through the bottom of the amplification reaction region.
- the plurality of cylindrical cavities include a piston container, such as the piston container 7 in FIG.
- the cavity and the piston 71 in the cavity, the piston can move up and down in the cavity.
- the plurality of piston containers communicate with each other through fluid channels 4 provided in the base plate.
- the fluid channel is located below the cavity and communicates with the opening 5 at the bottom of the cavity through an upward flow channel.
- piston valves are also included in the plurality of cylindrical cavities, such as piston valve 8 in FIG. 1, for controlling the fluid communication between the interconnected piston containers. .
- the piston valve includes a valve cavity surrounded by a piston wall perpendicular to the bottom plate and a valve piston 81 located in the valve cavity, and the bottom of the valve cavity (not the side wall) has flow passages connected to the upstream and downstream containers controlled by it respectively Two or more openings 6 in communication, the valve piston 81 can move to the bottom of the cavity and cover the opening 6, blocking the communication between the cavity and the fluid channel, thereby blocking the connection between the containers connected by the fluid channel of fluid communication.
- the fluid channel communicates with the opening at the bottom of the valve cavity through an upward channel from the bottom of the valve cavity.
- FIG. 2 is another perspective view of the partial structure of the exemplary chip device for detecting nucleic acid in a sample provided by the present invention in FIG. 1 .
- FIG. 2 does not show the internal thread on the cavity wall of the piston valve used in the chip device provided by the present invention and the piston movement control member in the cavity.
- the device for nucleic acid detection in a sample provided by the present invention has a sample receiving module, including a sampling chamber 101 and a sampling chamber 103 , and a sampling chamber valve 102 located between the sampling chamber 1 and the sampling chamber 3 .
- the original sample to be tested can be added into the sample loading chamber 101 .
- the sampling cavity valve 102 is a piston valve, with a piston in the valve cavity and two openings at the bottom of the valve cavity communicating with the flow channels in the substrate.
- the sampling cavity 103 is connected.
- the sampling cavity 103 is a piston-type container with a piston in the cavity and an opening at the bottom of the cavity that communicates with the flow channel in the substrate.
- the initial state of the device for nucleic acid detection in a sample is: the sampling chamber valve 102 is in a closed state (that is, the piston of the sampling chamber valve 102 is located at the bottom of the chamber and covers the opening, blocking the chamber communication with the fluid channel), the piston in the sampling chamber 103 is located at a specified height (at this time, the volume between the piston and the bottom of the sampling chamber is the specified volume, for example, the specified sample volume for the sample cracking reaction).
- the sampling chamber valve 102 When keeping the sampling chamber valve 102 in the closed state, add the sample in the sample chamber 101; then the sampling chamber valve 102 is opened (the piston of the sampling chamber valve 102 is about to rise), because the initial state of the sampling chamber 103 is a vacuum state, The solution in the sampling chamber 101 of the specified volume is sucked into the sampling chamber 103 through the sampling chamber valve 102; the sampling chamber valve 102 is closed (the piston of the sampling chamber valve 102 is pushed to the bottom of the chamber).
- the chip device used for nucleic acid detection in samples provided by the present invention has a sample lysis and nucleic acid extraction module, which includes a first mixing chamber 105 and a second mixing chamber 107, and is located between the first mixing chamber 105 and the second mixing chamber.
- a mixing chamber valve 106 between the two mixing chambers 107.
- the first mixing chamber 105 and the second mixing chamber 107 are both piston-type containers, with a piston inside the chamber, and an opening at the bottom of the chamber communicating with the flow channel in the substrate.
- the injection valve 104 and the mixing chamber valve 106 are both piston valves, with a piston in the valve cavity, and two openings at the bottom of the valve cavity that communicate with the flow channel in the substrate, and the two openings are respectively connected with the upstream and downstream Flow channels of the container phase: the two flow channels controlled by the sampling valve 104 communicate with the first mixing chamber 105 and the sampling chamber 103 respectively, and the two flow channels controlled by the mixing chamber valve 106 communicate with the first mixing chamber 105 and the second mixing chamber respectively.
- the cavity 107 communicates.
- the chip device for nucleic acid detection in this embodiment is particularly suitable for nucleic acid extraction from a sample by direct extraction, that is, the solution obtained after the sample contacts and reacts with a nucleic acid extraction reagent contains nucleic acid that can be used for subsequent amplification reactions.
- Samples suitable for nucleic acid extraction and amplification by direct extraction include artificially synthesized cloning liquid, in vitro transcribed RNA, plasmids, serum, plasma, urine, cotton swab eluate, sputum, alveolar lavage fluid, etc. .
- the nucleic acid extraction reagents used to extract the above samples usually contain lysing agents, including various surfactants such as SDS, Triton, NP-40, etc., and other chemical reagents such as buffers, protease inhibitors, reducing agents, etc., and various lysing agents Enzymes of components in the cell wall or cell membrane, such as Labiase lyase, lysostaphin, lysozyme from egg protein, human lysozyme, achromopeptidase, mutanolysin from Streptomyces coccidioides, chitinase, lysozyme Rhizoctonia-derived lyase, Arthrobacter luteus-derived lyase, Trichoderma harzianum-derived lyase, Streptococcus pyogenes-derived streptolysin O, Bacillus tetani-derived tetanolysin
- nucleic acid extraction reagent The main main function of described nucleic acid extraction reagent is: (1) utilize detergent to destroy lipid bilayer, rupture cell; (2) dissolve protein; (3) promote protein denaturation; (4) inhibit protease and nuclease active.
- Commercially available direct extraction nucleic acid extraction reagents such as the sample release agent (model S1014) provided by China Sunshine Biotechnology Co., Ltd.
- the initial state of the chip device for nucleic acid detection in a sample is: the sampling valve 104 and the mixing chamber valve 106 are in a closed state; Extraction reagents for nucleic acid extraction.
- the sampling chamber valve 102 is closed and there is a sample solution in the sampling chamber 103
- the sampling valve 104 is opened to move the piston of the sampling chamber 103 downward, and the sample solution in the sampling chamber 103 is pressed to the first mixing chamber 105, Dissolve the pre-placed direct extraction reagent; close the injection valve 104.
- the mixing chamber valve 106 is opened, and the pistons of the first mixing chamber 105 and the second mixing chamber 107 are alternately moved downward, so that the straight-lift nucleic acid extraction reagent is fully mixed and reacted with the sample solution, and the cells in the sample are lysed, The nucleic acid is released, and finally the piston of the first mixing chamber 105 moves downward, so that the solution containing the released and isolated nucleic acid flows into the second mixing chamber 107, and the valve 106 of the mixing chamber is closed.
- the nucleic acid extraction module further includes a dilution chamber 109 .
- the diluting chamber 109 is a piston-type container with a piston in the chamber and an opening communicating with the flow channel at the bottom of the chamber.
- the flow channels connected to the two openings communicate with the second mixing chamber 107 and the diluting chamber 109 respectively.
- the chip device for nucleic acid detection in this embodiment, after the nucleic acid is extracted from the sample, it usually needs to be diluted before being used for subsequent nucleic acid detection reactions, such as amplification reactions.
- the initial state of the chip device for nucleic acid detection in a sample is: the dilution valve 108 is in a closed state; Prepare diluent for diluting the extracted nucleic acid solution.
- the dilution valve 108 is opened, the piston of the second mixing chamber 107 moves downward, and the piston of the dilution chamber 109 moves upward, so that the second mixing chamber 107
- the solution of separated nucleic acids flows to the dilution chamber 109 .
- the pistons of the second mixing chamber 107 and the diluting chamber 109 are moved downward alternately, so that the nucleic acid sample solution is fully mixed.
- the piston of the second mixing chamber 107 moves downward, so that the nucleic acid-containing solution flows into the diluting chamber 109, and the diluting valve 108 is closed.
- the nucleic acid extraction module further includes a filter unit and a sample chamber 110 downstream of it to be amplified.
- the filter unit is a filter cavity 125, which is a piston-type container with a piston 126 in the cavity, and two openings that communicate with the dilution cavity 9 and the sample cavity 110 to be amplified respectively at the bottom of the cavity;
- the bottom has a filter element 127 for filtering unwanted substances (such as cells, cell fragments or large protein molecules, etc.) in the nucleic acid extraction solution.
- the filter element is prepared by using filter materials.
- the piston in the filter cavity is fixed in the cavity, and the space formed by the piston and the bottom of the cavity is filled with the filter material.
- the pore size of the filter material can allow the nucleic acid in the solution (including genomic nucleic acid or its fragments, etc.) to pass through freely, and retain tissue fragments, cells and cell fragments, or large protein molecules, etc.
- the filter material used does not physically adsorb or substantially does not physically adsorb the nucleic acid in the solution, and does not react or inhibit the nucleic acid.
- the initial state of the chip device for nucleic acid detection in a sample is: the piston 126 of the filter cavity 125 is fixed in the cavity and pressed on the top of the filter element 127; the sample to be amplified is The piston in chamber 110 is located at the bottom of the chamber.
- the piston in the dilution chamber 109 moves downward, and the piston in the sample chamber 110 to be amplified moves upward, thereby diluting
- the separated and diluted nucleic acid solution in the cavity 109 flows through the filter material 127 through the two openings of the filter cavity 110 and then flows into the sample cavity 110 to be amplified.
- a filter membrane may be provided in the flow channel between the second mixing chamber 107 and the sample chamber 109 to be amplified.
- a plurality of filter chambers or filter membranes or a combination thereof may be arranged between the second mixing chamber 107 and the sample chamber 109 to be amplified, and the multiple filter chambers or filter membranes may have different The size of the sieve is used to realize the multiple filtration of the nucleic acid-containing solution obtained after the nucleic acid extraction of the sample by the direct extraction method, which can avoid the clogging of the filter material.
- the chip device provided by the present invention for detecting nucleic acid in a sample does not need a filter chamber.
- the chip device for nucleic acid detection in samples provided by the present invention also has a nucleic acid amplification module.
- the nucleic acid amplification module has a multiple amplification unit, and the amplification unit includes a plurality of amplification reaction chambers 122 arranged in the bottom plate of the chip device and a plurality of amplification reaction chambers arranged in the plurality of amplification chambers.
- the multiple amplification sampling valve 121 above the reaction chamber 122 is added.
- the multiple amplification sample injection valve 121 is a piston valve, with a piston 123 in the valve cavity, and a flow channel communicating with the upstream sample cavity 110 to be amplified in the center of the bottom of the valve cavity.
- An opening 124 and a plurality of openings 125 connected to the flow channels of each of the plurality of amplification reaction chambers 122 are provided in the circumference of the bottom of the valve cavity.
- the plurality of amplification reaction chambers 122 are arranged in the bottom plate of the chip below the valve chamber of the multiple amplification sampling valve 121, which can accommodate the reactants or reaction systems of the amplification reaction, and the nucleic acid extraction module.
- the isolated nucleic acid solution can be subjected to an amplification reaction under suitable conditions.
- the nucleic acid amplification module in the chip device may have multiple nucleic acid amplification units, such as 2 or 4 or 6 or 8 units.
- multiple amplification can be used to detect multiple target sequences on the nucleic acid of the same sample under the same reaction conditions.
- multiplex PCR multiplex PCR
- multiplex PCR that is, a PCR reaction in which different primer pairs are used in the same PCR reaction system to simultaneously amplify multiple nucleic acid fragments.
- the initial state of the chip device for nucleic acid detection in a sample is: different primer pairs, probes, One or more of reactants such as enzymes (in another exemplary working situation, the enzyme is pre-set in the sample chamber 110 to be amplified, and is dissolved in the solution after adding the diluted nucleic acid sample solution) , and kept in a vacuum state; the piston of the multiple amplification sampling valve 121 is located at the bottom of the cavity, sealing the opening 124 communicating with the flow channel connected to the upstream sample cavity 110 to be amplified and each of the multiple amplification reaction The cavity 122 communicates with the opening 125 .
- reactants such as enzymes
- the piston of the multiple amplification sampling valve 121 is moved upwards, thereby making the nucleic acid sample in the sample chamber 110 to be amplified
- the solution enters the cavity of the multiple amplification sampling valve 121 and then is evenly dispensed into the multiple amplification reaction cavities 122 .
- nucleic acid amplification reactions can be performed in the plurality of amplification reaction chambers 122 .
- Various nucleic acid amplification methods using primers known in the art can be used in the present invention, including variable temperature or isothermal amplification methods, such as polymerase chain reaction (PCR), strand displacement amplification (SDA), nucleic acid sequence-based Amplification (NASBA), cascade rolling circle amplification (CRCA), loop-mediated DNA isothermal amplification (LAMP), isothermal and chimeric primer-initiated nucleic acid amplification (ICAN), target-based unwinding Enzyme-dependent amplification (HDA), transcription-mediated amplification (TMA), etc.
- PCR polymerase chain reaction
- SDA strand displacement amplification
- NASBA nucleic acid sequence-based Amplification
- CRCA cascade rolling circle amplification
- LAMP loop-mediated DNA isothermal amplification
- ICAN isothermal and chimeric primer-initiated nucle
- a variable temperature amplification method such as PCR
- the nucleic acid amplification module of the device also includes a temperature control unit for the plurality of amplification reaction chambers 122, for example, a temperature regulator , the amplification reaction chamber 122 is cyclically heated and cooled according to a predetermined program and lasts for a predetermined time.
- the nucleic acid amplification module of the device also includes a temperature control unit for the plurality of amplification reaction chambers 122, for example, a temperature regulator , so that the amplification reaction chamber 122 maintains a constant temperature.
- a temperature control unit for the plurality of amplification reaction chambers 122 for example, a temperature regulator
- the chip device for detecting nucleic acid in a sample may also include a signal detection module (not shown in the figure) for detecting the detection results of each amplification reaction chamber 122 .
- the detection module of the present invention is a module suitable for detecting identifiable labels carried by nucleic acids in any manner, including but not limited to fluorescence or other forms (such as chemiluminescence, bioluminescence, radioluminescence, electroluminescence, electrochemiluminescence, Mechanical luminescence, crystalline luminescence, thermoluminescence, sonoluminescence, phosphorescence and photoluminescence, etc.) luminescence, enzymatic reactions, radioactivity, etc.
- the amplification reaction chambers of the amplification reaction unit are insulated by materials that completely absorb or substantially completely absorb the signals generated by the amplification reaction, so as to avoid the gap between adjacent amplification reaction chambers.
- the wall of the amplification reaction unit can be made of a material that completely absorbs or substantially completely absorbs the signal generated by the amplification reaction.
- the bottom of the amplification reaction chamber is prepared or sealed with a material that does not absorb at all or substantially does not absorb the signal to be detected.
- the detection of the amplified nucleic acid is by detecting the fluorescent signal carried by the nucleic acid.
- the probes, primers and oligonucleotides contained in the reaction system of the amplification reaction chamber 122 can be detectably labeled radioactively, fluorescently or non-radioactively by methods well known to those skilled in the art.
- the bottom of the amplification reaction chamber 122 is prepared or sealed with a material that does not absorb at all or substantially does not absorb the signal to be detected.
- the signal detection module disposed in the chip or an external detection system can detect the fluorescent signals generated in each amplification reaction chamber 122 through the bottom of the amplification reaction chamber 122 . Commonly used fluorescent dyes and their signal-related wavelengths are shown in Table 1 below.
- the bottom of the amplification reaction chamber 122 can be made of a material that does not absorb the fluorescent signal generated by the amplification reaction.
- various known optical systems including optical filters, cameras, etc. can be used to collect and analyze the fluorescence signals generated at the bottom of each amplification reaction chamber 122 to obtain detection results.
- the piston container eg
- the piston container is used to accommodate solid or liquid preparations or to conduct reactions.
- Liquid formulations can be transferred between interconnected containers through fluid channels.
- the solid formulation can be formed into a solution after addition of a suitable solvent, and then transferred between interconnected containers through fluid channels.
- two or more piston containers can be used to control the flow of fluid (stationary or moving), as well as its flow direction and/or flow rate.
- the liquid can be mixed effectively through two or more piston containers connected.
- the pistons of the first mixing chamber 105 and the second mixing chamber 107 can be moved down alternately, so that the direct extraction nucleic acid extraction reagent and the sample solution are fully mixed and reacted.
- the movement of the piston in the cavity can be controlled by mechanical transmission.
- the piston is fixedly connected with the connecting rod, and the position of the piston in the cavity is controlled by pushing and pulling the connecting rod.
- the piston moves to the bottom of the cavity, it can continue to apply pressure, thereby deforming the piston, sealing the opening where the fluid channel communicates with the cavity, and completely blocking the fluid communication between the fluid channels.
- the movement of the piston can also be controlled by other means, such as pneumatic transmission or hydraulic transmission.
- the movement of the piston in the piston valve in the cavity can be controlled by a piston movement control mechanism.
- the piston movement control mechanism includes a piston movement control member 82 arranged above the piston 81 in the cavity, the piston movement control member 82 has an external thread, and is connected to the cavity wall of the piston.
- the inner thread of the piston forms a thread pair, and when the piston movement control member 82 is rotated along the thread, it moves upward or downward in the cavity of the piston, thereby controlling the upward or downward movement of the piston.
- FIG. 4 is a schematic diagram of the structure and working mode of the aforementioned exemplary piston valve and piston motion control mechanism in the chip device provided by the present invention.
- Fig. 4(a) is a schematic cross-sectional view of the structure of the exemplary piston valve
- Fig. 4(b) and (c) are schematic views of the working mode of the exemplary piston valve.
- the piston 81 is located in a cavity 83 formed by the space limited by the cavity wall, and can move up and down in the cavity.
- the piston is movable into full contact with the bottom of the cavity and covers the opening 43 through which all fluid channels (eg, fluid channels 41 and 42 as shown) communicate with the cavity, thereby blocking fluid communication.
- the piston movement control member 82 is arranged above the piston 81 and has an external thread 821 forming a thread pair with the internal thread 831 on the cavity wall of the piston valve. As the piston motion control member 82 is threaded, it moves upward or downward within the cavity of the piston.
- Figure 4(b) and (c) are schematic diagrams of the working mode of the exemplary piston valve, wherein Figure 4(b) shows an exemplary working mode of controlling the downward movement of the piston, and Figure 4(c) shows an exemplary control How the upward movement of the piston works.
- the movement of the piston motion control member 82 is regulated by the control mechanism 84 of the piston motion control member. As shown in FIG.
- the control mechanism includes a control rod 841 and a motor 842 .
- the lever can be rotated and/or moved up and down.
- the control rod movement motor can be an electric batch, which can set parameters such as the rotation direction, rotation speed, rotation angle, and stop torque of the control rod.
- the piston movement control member 82 has a cavity 822 suitable for inserting a control rod, and the cross section of the cavity is in a shape adapted to the control rod (such as the hexalobe screw in the embodiment shown in FIG. 4( b )).
- Fig. 4(b) is a schematic diagram of controlling the downward movement of the piston movement control member.
- the clockwise rotation of the control rod can drive the piston motion control part 82 to rotate along the screw thread, and the piston motion control part 82 is generated in the cavity. downward movement.
- the control rod is insertable in a slowly rotating manner into the cavity of the piston motion control member. Inserting while rotating allows the ribs on the lever to engage with the interior of the cavity, effectively solving the alignment problem.
- the bottom of the piston has a piston supporting body 812, which is a protrusion at the bottom of the piston, made of elastic material, and will be deformed and compressed when subjected to pressure.
- a piston supporting body 812 which is a protrusion at the bottom of the piston, made of elastic material, and will be deformed and compressed when subjected to pressure.
- the piston is under pressure (for example, when the piston motion control member rotates along the thread and moves toward the piston in the cavity, contacts the piston and pushes it to the bottom of the cavity), the piston support body 812 is compressed to the entire bottom of the piston and the cavity
- the bottom of the bottom fully contacts and covers the opening 43 that all fluid passages (fluid passages 41 and 42 as shown in the figure) communicate with the cavity, thus blocking the fluid communication of each fluid passage (as shown in Figure 5 (b).
- the piston support body 812 When the piston When the received pressure disappears (for example, when the piston motion control member is threaded and moves away from the piston in the cavity), the piston support body 812 returns to its natural deformation state (that is, the piston support body under no additional pressure on the piston) 812 natural deformation), in this state, the position where the piston support body contacts the bottom of the piston does not cover any opening 43 where any fluid channel communicates with the cavity, and each fluid channel generates fluid communication with each other through the cavity. By adjusting The movement distance of the control rod is used to adjust the contact and compression of the piston motion control part 82 and the piston 81.
- the limit 823 to the piston motion control part can be set at the top of the chamber wall, so that when the piston motion control part moves to the limit, After the torque received by the control rod in the piston movement control part exceeds the stop torque value set by the electric batch, the electric batch stops the rotation of the motor, and then the control rod can be pulled out.
- Fig. 4(c) is a schematic diagram of controlling the upward movement of the piston movement control member.
- the counterclockwise rotation of the control rod can drive the piston movement control member 82 to rotate along the thread, and the piston movement control member moves upward in the cavity.
- the piston support body 812 returns to its natural deformation state (that is, the natural deformation of the piston support body under no additional pressure on the piston), where In this state, the part of the piston support body in contact with the bottom of the piston does not cover any opening where the fluid channel communicates with the cavity, and each fluid channel communicates with each other through the cavity.
- the piston movement control part moves to the top, because of the existence of the limit position 823, the torque increases. After exceeding the stop torque value set by the electric batch, the electric batch will stop the rotation of the control rod, and then the control rod can be pulled out.
- the initial working state of the piston in the aforementioned piston container is located at a specified height in the cavity.
- the piston in the sampling chamber 103 in FIG. 2 is at a specified height in the initial working state (at this time, the volume between the piston and the bottom of the sampling chamber is a specified volume, such as the specified sample volume for the sample cracking reaction).
- the positioning of the piston in the cavity can be achieved by increasing the friction between the piston and the piston wall by etching internal threads on the piston wall or the like.
- the cavity wall of the piston container 3 has an internal thread 31 , and the lower end of the internal thread is the upper end of the predetermined piston position.
- FIG. 5 is a perspective view of yet another exemplary chip device used in the detection of nucleic acid in a sample provided by the present invention.
- the figure does not show the internal thread on the cavity wall of some piston containers or piston valves in the chip device provided by the present invention and the piston movement control parts in the cavity of the piston valve.
- FIG. 6 is another perspective view of the exemplary chip device for nucleic acid detection in a sample shown in FIG. 5 .
- the figure does not show the piston in the piston container or the piston valve in the chip device provided by the present invention.
- FIG. 7 is a schematic diagram of the top-view structure of the exemplary chip device for detecting nucleic acid in a sample shown in FIG. 5 and the communication relationship of its flow channels.
- the chip device for nucleic acid detection in samples provided by the present invention includes a substrate 1 and a container area 2 perpendicular to the substrate, and a plurality of cylindrical cavities are arranged in the container area.
- the cylindrical cavity is bounded by walls of the container area perpendicular to the bottom plate.
- the plurality of cylindrical cavities communicate with each other through fluid channels provided in the bottom plate.
- the fluid channel is located below the cavity and communicates with the opening at the bottom of the cavity through an upward flow channel.
- the chip device used for nucleic acid detection in samples provided by the present invention has a sample receiving module, including a sample loading chamber 201 and a sampling chamber 203, and a Sampling cavity valve 202.
- the sample to be tested can be added into the sample loading chamber.
- water or other suitable solutions such as PBS buffer can be added to the sample loading chamber.
- the sampling chamber valve 202 is a piston valve with a piston inside the valve chamber and two openings at the bottom of the valve chamber that communicate with the flow channel in the substrate.
- the flow channels communicate with the sampling chamber 201 and the sampling chamber 203 respectively.
- the sampling cavity 203 is a piston-type container with a piston in the cavity and an opening at the bottom of the cavity that communicates with the flow channel in the substrate.
- the initial state of the device for nucleic acid detection in a sample is: the sampling cavity valve 202 is in a closed state (that is, the piston of the sampling cavity valve 202 is located at the bottom of the cavity and covers the opening, blocking the cavity communication with the fluid channel), the piston in the sampling chamber 203 is at a specified height (the volume between the piston and the bottom of the sampling chamber is a specified volume at this time, for example, the specified sample volume for the sample cracking reaction).
- the sampling chamber valve 202 When keeping the sampling chamber valve 202 in the closed state, add the sample in the sample chamber 201; then the sampling chamber valve 202 is opened (the piston of the sampling chamber valve 202 is about to rise), because the initial state of the sampling chamber 203 is a vacuum state, The solution in the sampling chamber 201 of the specified volume is sucked into the sampling chamber 203 through the sampling chamber valve 202; the sampling chamber valve 202 is closed (the piston of the sampling chamber valve 202 is pushed to the bottom of the chamber).
- the chip device for nucleic acid detection in the sample has a sample lysis and nucleic acid extraction module, which includes a first mixing chamber 205 and a second mixing chamber 207, and is located in the first mixing chamber Mixing chamber valve 206 between 205 and second mixing chamber 207. There is also a sampling valve 204 between the sampling chamber 203 and the first mixing chamber 205 .
- both the first mixing chamber 205 and the second mixing chamber 207 are piston-type containers with pistons inside the chambers.
- the sampling valve 204 and the mixing chamber valve 206 are both piston valves.
- the flow channels of the upstream and downstream container phases the two flow channels controlled by the sampling valve 204 communicate with the first mixing chamber 205 and the sampling chamber 203 respectively, and the two flow channels controlled by the mixing chamber valve 206 communicate with the first mixing chamber 205 and the second mixing chamber respectively.
- the two mixing chambers 207 are connected.
- the chip device for nucleic acid detection in this embodiment is suitable for nucleic acid extraction after lysing the sample by lysing method, that is, after the sample contacts and reacts with the sample lysing reagent, it needs to be further processed by nucleic acid extraction methods such as magnetic bead method to obtain usable Nucleic acid in subsequent amplification reactions.
- nucleic acid extraction methods such as magnetic bead method to obtain usable Nucleic acid in subsequent amplification reactions.
- the nucleic acid is bound by contacting the nucleic acid-binding magnetic material and/or binding solution with the sample that has been lysed, thereby allowing the nucleic acid to bind to the magnetic material.
- the complex formed after the nucleic acid is combined with the magnetic material can controllably move, stir or precipitate in the container under the action of a magnetic field, so as to achieve the purposes of nucleic acid binding, nucleic acid cleaning and nucleic acid elution.
- the nucleic acid extraction module in the chip device provided by the present invention is composed of a binding unit, a cleaning unit and an elution unit, and nucleic acid is extracted through nucleic acid binding, cleaning and elution steps, wherein nucleic acid binding, nucleic acid cleaning and nucleic acid elution reagents need to be added ( Including nucleic acid extraction magnetic beads, washing solution, eluent, etc.).
- the chip device for detecting nucleic acid in a sample has a sample lysis and nucleic acid extraction module, which includes a sample lysis module and a nucleic acid extraction module.
- the sample lysing module includes a lysing reagent storage chamber 215 for accommodating a lysing reagent (solid), and a lysing reagent valve 225 located between the first mixing chamber 205 and the lysing reagent storage chamber 215 .
- the lysing reagent valve is a piston valve, comprising a valve cavity and a valve piston positioned in the valve cavity.
- the piston can move to the bottom of the chamber and cover the openings, blocking the fluid communication between the lysis reagent storage chamber and the chamber where sample lysis is performed (eg, the first mixing chamber 205 ).
- said nucleic acid extraction module comprises three nucleic acid cleaning reagent storage chambers 213, 214 and 216 that accommodate nucleic acid cleaning reagents (solid), and the first mixing chamber 205 and each of said nucleic acid cleaning reagent storage chambers 213, 214 and Nucleic acid cleaning reagent valves 223, 224, 226 between 216.
- the nucleic acid extraction module also includes a nucleic acid elution reagent storage cavity 217 for holding a nucleic acid elution reagent (solid), and a nucleic acid cleaning reagent valve 227 between the first mixing chamber 205 and the nucleic acid elution reagent storage cavity 217 .
- the sample lysis and nucleic acid extraction module of the chip device for nucleic acid detection in samples provided by the present invention also includes a water adding chamber 211 and a water inlet valve 212 .
- the water inlet valve 212 is a piston valve, has a piston in the valve cavity, and has an opening 2121 communicated with the water adding cavity 211 at the bottom of the valve cavity, and is connected with the lysing reagent storage cavity 215 and the nucleic acid cleaning reagent storage cavity 213, 214 respectively. , 216 and five openings 2122 communicating with the nucleic acid eluting reagent storage cavity 217.
- the initial state of the chip device for nucleic acid detection in a sample is: the water inlet valve 212, the lysing reagent valve 225, the nucleic acid cleaning reagent valves 223, 224, 226 and the nucleic acid cleaning reagent valve 227 are in Disabled.
- the water inlet valve 212 When starting to work, add distilled water to the water adding chamber 211, open the water inlet valve 212, and the distilled water in the water adding chamber 211 will be sucked into the lysing reagent storage chamber 215, nucleic acid cleaning reagent storage chambers 213, 214, 216 and nucleic acid eluting reagent storage chambers. chamber 217, and reconstitute the reagents therein.
- the initial state of the chip device for nucleic acid detection in the sample is: the sampling valve 204 and the mixing chamber valve 206 are closed; the second mixing chamber 207 is preloaded with magnetic beads that can bind nucleic acid.
- the sampling chamber valve 202 is closed and there is a sample solution in the sampling chamber 203, open the sampling valve 204 to move the piston of the sampling chamber 203 downward, and press the sample solution in the sampling chamber 203 to the first mixing chamber 205; Close injection valve 204.
- nucleic acid cleaning reagent storage chambers 214 and 216 The same operation is performed on the nucleic acid cleaning reagent storage chambers 214 and 216 in sequence to complete the second and third cleaning of the magnetic beads adsorbed nucleic acid.
- a magnetic device such as a magnet is placed close to the first mixing chamber 205 and/or the second mixing chamber 207, so that the magnetic beads are attracted on the wall of the chamber, and finally the piston of the first mixing chamber 205 moves downward, so that the nucleic acid contained in the released separation
- the solution flows into the second mixing chamber 207, and the mixing chamber valve 206 is closed.
- all or part of the components (such as enzymes) in the sample lysing reagent can be preloaded in the first mixing chamber 205 .
- the lysing reagent, nucleic acid cleaning reagent and nucleic acid eluting reagent of the lysing reagent (solid) in the sample lysing and nucleic acid extraction module in the chip device for nucleic acid detection in the sample of the present invention can also be liquid The form is preset in the lysing reagent storage chamber, the nucleic acid washing reagent storage chamber or the nucleic acid eluting reagent storage chamber.
- the nucleic acid extraction module further includes a mixing chamber 209 for a sample to be amplified and a chamber 210 for a sample to be amplified.
- the mixing chamber 209 for the sample to be amplified and the chamber 210 for the sample to be amplified are piston-type containers with a piston inside the chamber and an opening at the bottom of the chamber communicating with the flow channel.
- a sample valve 208 to be amplified which is a piston valve with a piston in the valve chamber and a flow channel connected to the substrate at the bottom of the valve chamber.
- the two openings communicate with each other, and the flow channels connected by the two openings communicate with the second mixing chamber 207 and the sample mixing chamber 209 to be amplified respectively.
- the initial state of the chip device for nucleic acid detection in a sample is: the sample to be amplified valve 208 is in a closed state; the sample to be amplified mixing chamber 209 and/or the sample to be amplified chamber 210 Reagents (such as common amplification reagents such as enzymes or buffer reagents, etc., but not including reagents for specific amplification, such as specific primers or probes) that are pre-installed in the kit for subsequent nucleic acid detection reactions (such as amplification reactions) Wait).
- Reagents such as common amplification reagents such as enzymes or buffer reagents, etc., but not including reagents for specific amplification, such as specific primers or probes
- the piston of the second mixing chamber 207 moves downward, and the piston of the sample mixing chamber 209 to be amplified moves upward, so that The solution of the separated nucleic acid in the second mixing chamber 207 flows to the sample mixing chamber 209 to be amplified.
- the piston of the sample chamber 210 to be amplified is moved upwards at the same time, so that the solution of the separated nucleic acid flows to the sample to be amplified.
- the chip device for nucleic acid detection in a sample provided by the present invention also has a nucleic acid amplification module.
- the nucleic acid amplification module includes a plurality of amplification reaction chambers 222 arranged in an array arranged in the bottom plate of the chip device, wherein each amplification reaction chamber 222 passes through a branch channel 229 communicates with branch channels 2291 between every two rows of amplification reaction chambers, and multiple branch channels 2291 merge at both ends of the amplification reaction chamber array to form a main channel 228 .
- the main channel 2281 at one end of the amplification reaction chamber array communicates with the upstream multiple amplification sampling valve 221.
- the multiple amplification sampling valve 221 is a piston valve with a piston in the valve cavity and a valve at the bottom of the valve cavity. Two openings communicating with the flow channels in the substrate, the flow channels connected by the two openings communicate with the sample cavity 210 to be amplified and the main flow channel 2281 respectively.
- an inert liquid such as mineral oil can be used to seal the outlet of the chamber for nucleic acid amplification reaction.
- the nucleic acid amplification module of the chip device for nucleic acid detection in samples provided by the present invention further includes an inert liquid module for storing the inert liquid and transferring the inert liquid.
- the inert liquid module has an oil filling chamber for storing and providing an inert liquid (such as mineral oil or paraffin oil) that seals the interface between the amplification reaction chamber and the branch flow channel; optionally, it also includes an oil filling chamber and multiple amplification zone units
- the refueling valve between them is a piston valve, with a piston in the valve cavity, and an opening communicating with the flow channel communicating with the refueling cavity and an opening communicating with the amplification zone unit at the bottom of the valve cavity.
- the inert liquid module includes an oil filling cavity 231 .
- the refueling valve 230 is a piston valve with a piston in the valve chamber and a Two openings connected by the flow channel in the base plate, the flow channels connected by the two openings communicate with the oil filling chamber 231 and the main flow channel 2282 respectively.
- the initial state of the chip device for nucleic acid detection in a sample is: different primer pairs, probes, etc.
- One or more of reactants such as needles and enzymes
- the enzyme is preset in the sample chamber 210 to be amplified, and after adding the diluted nucleic acid sample solution, dissolves in the solution), and kept in a vacuum state; the piston of the multiple amplification sampling valve 221 is located at the bottom of the cavity, and closes the opening communicating with the flow channel connected to the upstream sample chamber 210 to be amplified and the opening communicating with the main flow channel 2281.
- the piston of the multiple amplification sampling valve 221 is moved upwards, thereby making the nucleic acid sample in the sample chamber 210 to be amplified
- the solution enters the cavity of the multiple amplification sampling valve 221 , then enters each branch flow channel 229 through the main flow channel 2281 and the branch flow channel 2291 , and finally is evenly distributed into the multiple amplification reaction chambers 222 .
- the initial state of the chip device for nucleic acid detection in a sample is: the refueling valve 230 is in a closed state; the refueling cavity 231 is pre-filled with mineral oil.
- the reaction systems have been divided into the multiple amplification reaction chambers 222, open the refueling valve 230, press down the piston of the refueling chamber 231, and the mineral oil present in the refueling chamber 231 will pass through the refueling valve 230 and enter the main channel 2282
- the mineral oil passes through the branch flow channel 2291, closes each branch flow channel 229, and then passes through the main flow channel 2281 and flows through the multiple amplification sampling valve 221 into the sample chamber to be amplified 210 and the sample mixing chamber 209 to be amplified . Close the filling valve 230 and the multiple amplification sampling valve 221.
- the mineral oil pre-stored in the oiling chamber 231 is excessive, which can ensure that the connections between the various amplification reaction chambers
- Nucleic acid amplification reactions can be performed in the plurality of amplification reaction chambers 222 .
- various nucleic acid amplification methods using primers known in the art can be used in the present invention.
- a variable temperature amplification method such as PCR is used.
- an isothermal amplification method such as LAMP is used.
- the detection module used to detect each amplification reaction chamber 222 is a module suitable for detecting identifiable labels carried by nucleic acids in any manner, including but not limited to fluorescence or other forms of luminescence, enzymatic reactions, radioactivity, and the like.
- the piston container eg
- the piston container is used to contain solid or liquid preparations or to perform reactions.
- Liquid formulations can be transferred between interconnected containers through fluid channels.
- the solid formulation can be formed into a solution after addition of a suitable solvent, and then transferred between interconnected containers through fluid channels.
- two or more pistons are used to control the flow of fluid (stationary or moving), as well as its flow direction and/or flow rate.
- the piston valve in the chip device for nucleic acid detection in samples provided by the present invention can adopt the piston and the piston motion control mechanism as described in FIG. 4 .
- the initial working state of the piston in the aforementioned piston container is located at a certain specified height in the cavity.
- the positioning of the piston in the cavity can be achieved by increasing the friction between the piston and the piston wall by etching internal threads on the piston wall or the like.
- Embodiment 3 is used for the instrument of nucleic acid detection in the sample
- the present invention provides an instrument for nucleic acid detection in a sample, which is a POCT instrument, which includes the chip device defined and described in Example 1 or 2.
- the instrument has a chip device receiving and motion control system for receiving and transferring the above chip device to a designated position within the instrument for various processes on the chip.
- the instrument has a magnet and a system to control the movement of the magnet, and is used to purify nucleic acid in a sample using the magnetic bead method.
- the nucleic acid is bound by contacting the nucleic acid-binding magnetic material and/or binding solution with the sample that has been lysed, thereby allowing the nucleic acid to bind to the magnetic material.
- the complex formed after the nucleic acid is combined with the magnetic material can controllably move, stir or precipitate in the container under the action of a magnetic field, so as to achieve the purposes of nucleic acid binding, nucleic acid cleaning and nucleic acid elution.
- the instrument has a control mechanism for regulating the movement of a piston motion control in the piston valve.
- the control mechanism includes a control rod and a control rod movement mechanism, the control rod can rotate or move up and down, wherein the control rod movement mechanism includes a component for controlling the control rod up and down movement and rotation, Such as motors.
- the instrument has a signal detection module for detecting nucleic acid amplification products, such as a fluorescence detection system.
- the instrument has a temperature control system for the nucleic acid amplification area of the chip.
- the instrument has a nucleic acid amplification result analysis and/or output system.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Sustainable Development (AREA)
- Virology (AREA)
- Clinical Laboratory Science (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Mechanical Engineering (AREA)
- General Physics & Mathematics (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
染料名称 | 激发波长 | 发射波长 |
FAM/SYBGREEN | 492nm | 516nm |
HEX/JOE/VIC | 535nm | 555nm |
ROX/TEXRED | 585nm | 610nm |
CY5 | 635nm | 665nm |
Claims (17)
- 一种用于样品中核酸检测的芯片装置,其具有基板和活塞式容器,所述活塞式容器之间通过微流体通道连通,其中,所述活塞式容器包括腔体和位于腔体内的活塞,腔体底部具有与所述微流体通道连通的开口,所述芯片装置还具有位于容器之间的活塞阀,用于控制相互连通的容器之间的流体连通,所述活塞阀包括阀腔体和位于阀腔体内的阀活塞,阀腔体底部具有与流道连通的两个或多个开口,阀活塞可运动到腔体底部和掩盖所述开口,阻断腔体与流体通道的连通,由此阻断通过所述流体通道相连的容器之间的流体连通,其中,所述芯片装置包括:样品接收模块;样品裂解和核酸提取模块,可用于对样品进行裂解反应和/或核酸提取反应,从样品中获得纯化的核酸;所述样品裂解和提取模块中具有样品裂解模块和/或核酸提取模块,任选的,所述核酸提取模块包括核酸结合单元、核酸清洗单元和核酸洗脱单元;和核酸扩增模块,用于将核酸样品分配到多个扩增区容器以及对核酸分子进行扩增和/或检测;核酸扩增模块包括多重扩增区模块和任选的前置扩增区模块。
- 根据权利要求1所述的芯片装置,其特征在于,所述样本接收模块包括取样腔,其为活塞式容器,包括腔体和位于腔体内的活塞;优选的,所述样本接收模块包括加样腔和取样腔,还包括加样腔和取样腔之间的取样腔阀,其为活塞阀。
- 根据权利要求1所述的芯片装置,其特征在于,所述样品裂解和提取模块包括第一混合腔和第二混合腔,所述第一混合腔和第二混合腔为活塞式容器,包括腔体和位于腔体内的活塞,优选的,所述第一混合腔和第二混合腔之间具有混合腔阀,其为活塞阀,更优选的,所述第一混合腔与上游的样本接收模块(例如其中的取样腔)之间具有进样阀,其为活塞阀,包括阀腔体和位于阀腔体内的阀活塞。
- 根据权利要求1-3中任一项所述的芯片装置,其特征在于,所述样品裂解和核酸提取模块的样品裂解模块包括用于容纳裂解试剂的裂解试剂存储腔,其为活塞式容器,包括腔体和位于腔体内的活塞,任选的,所述样品裂解模块还包括所述裂解试剂存储腔与进行样品裂解的腔体之间的裂解试剂阀,所述裂解试剂阀为活塞阀,优选的,所述样品裂解和核酸提取模块的具有结合单元、清洗单元和洗脱单元中的一个或多个,其分别具有用于容纳核酸结合试剂、核酸清洗试剂和核酸洗脱试剂的核酸结合试剂存储腔、核酸清洗试剂存储腔和核酸洗脱试剂存储腔,所述核酸结合试剂存储腔、核酸清洗试剂存储腔和核酸洗脱试剂存储腔为活塞式容器,包括腔体和位于腔体内的活塞,任选的,所述核酸结合试剂存储腔、核酸清洗试剂存储腔和核酸洗脱试剂存储腔分别通过核酸结合试剂阀、核酸清洗试剂阀或核酸洗脱试剂阀与进行核酸结合、核酸试剂或核酸洗脱反应的腔体连通,所述核酸结合试剂阀、核酸清洗试剂阀或核酸洗脱试剂阀为活塞阀。
- 根据权利要求1所述的芯片装置,其特征在于,所述样品裂解和提取模块还包括待扩增样品腔,其为活塞式容器,包括腔体和位于腔体内的活塞,用于容纳经裂解和提取的核酸溶液样品,优选的,在待扩增样品腔的上游还具有活塞阀,其包括阀腔体和位于阀腔体内的阀活塞。
- 根据权利要求1所述的芯片装置,其特征在于,所述样品裂解和提取模块还包括稀释腔,优选的,所述稀释腔与其上游模块或单元(例如第二混合腔)之间具有稀释阀,其为活塞式容器。
- 根据权利要求1所述的芯片装置,其特征在于,所述核酸扩增模块具有一个或多个多重扩增区单元,所述多重扩增区单元包括用于进行核酸扩增反应的多个扩增反应腔,通过微流道将来自样品裂解和提取模块的核酸样品溶液分配到各个所述扩增反应腔,任选的,所述多重扩增区单元与上游的样品裂解和提取模块之间(如在所述多重扩增区单元和上游的待扩增样品腔之间)具有活塞阀。
- 根据权利要求7所述的芯片装置,其特征在于,所述多重扩增区单元的多个扩增反应腔沿圆周分布,任选的,在其上方具有多重扩增进样阀,其为活塞阀,阀腔体内具有活塞,在其阀腔体底部具有与上游的待扩增样品腔连通的流道相通的开口,以及多个分别与下方的所述多个扩增反应腔 的每一个连通的开口。
- 根据权利要求7所述的芯片装置,其特征在于,所述多重扩增区单元的多个扩增反应腔以阵列形式排列,任选的,每个扩增反应腔通过支线流道与所述扩增区单元的主流道连通,所述多重扩增区单元的主流道与上游的样品裂解和提取模块相连通。
- 根据权利要求1所述的芯片装置,其特征在于,所述核酸扩增模块具有惰性液体模块,用于储存和提供封闭扩增反应腔与流道接口的惰性液体(如矿物油或石蜡油),例如,所述惰性液体模块具有加油腔,任选的,还包括加油腔与多重扩增区单元之间的加油阀,其为活塞阀,阀腔体内具有活塞,在其阀腔体底部具有与加油腔连通的流道相通的开口,以及与所述扩增区单元相通的开口。
- 根据权利要求1所述的芯片装置,其特征在于,所述核酸扩增模块还具有设置在所述多重扩增区单元上游的前置扩增区单元,用于对核酸分子进行第一轮扩增,例如进行巢式扩增,所述前置扩增区单元具有巢式扩增腔,例如,其为设置在底板内的圆柱状腔体,其具有分别与上游的样品裂解和提取模块和下游的重扩增区单元连通的流道。
- 根据权利要求1-11中任一项所述的芯片装置,其特征在于,所述活塞阀具有设置在阀活塞上方的活塞运动控制件,用于控制阀活塞在腔体内的上下运动。
- 根据权利要求1-12所述的芯片装置,其特征在于,所述活塞阀的阀腔体的腔壁具有内螺纹,所述活塞运动控制件具有外螺纹,与所述腔壁的内螺纹形成螺纹副,活塞运动控制件沿螺纹转动而在腔体内产生移动,控制所述活塞在腔体内的移动,所述活塞运动控制件具有适合插入控制杆的空腔,所述空腔横截面为与控制杆适配的形状。
- 根据权利要求1-13中任一项所述的芯片装置,其特征在于,所述活塞阀机构的阀活塞的底部具有活塞支撑体,所述活塞支撑体为位于活塞底部的凸起,其由具有弹性的材料制备。
- 一种用于样品中核酸检测的仪器(优选为POCT仪器),其中包括权利要求1-14中任一项所述的芯片装置,其中所述芯片装置具有基板和活塞式容器,所述活塞式容器之间通过微流体通道连通,其中,所述活塞式容器包括腔体和位于腔体内的活塞,腔体底部具有与所述微流体通道连 通的开口,所述芯片装置还具有位于容器之间的活塞阀,用于控制相互连通的容器之间的流体连通,所述活塞阀包括阀腔体和位于阀腔体内的阀活塞,阀腔体底部具有与流道连通的两个或多个开口,阀活塞可运动到腔体底部和掩盖所述开口,阻断腔体与流体通道的连通,由此阻断通过所述流体通道相连的容器之间的流体连通(所述流体通道从腔体下方通过向上的流道与所述腔体的底部的开口连通),其中,所述芯片装置包括:样品接收模块;样品裂解和核酸提取模块,可用于对样品进行裂解反应和/或核酸提取反应,从样品中获得纯化的核酸;所述样品裂解和提取模块中具有样品裂解模块和/或核酸提取模块,任选的,所述核酸提取模块包括核酸结合单元、核酸清洗单元和核酸洗脱单元;和核酸扩增模块,用于将核酸样品分配到多个扩增区容器(例如为扩增反应腔)以及对核酸分子进行扩增和/或检测;核酸扩增模块包括多重扩增区模块和任选的前置扩增区模块。
- 根据权利要求15所述的仪器,其特征在于,其还任选包括:其具有芯片装置接收和运动控制系统;磁体和控制磁体移动的系统;调节所述活塞阀中的活塞运动控制件的运动的控制机构,所述控制机构包括控制杆和控制杆运动机构,控制杆可进行旋转或上下运动,其中所述控制杆运动机构包括控制所述控制杆上下运动和旋转的部件,例如电机;检测核酸扩增产物的信号检测模块,例如为荧光检测系统;对所述芯片的核酸扩增区域进行温控的系统;核酸扩增结果分析和/或输出系统。
- 一种采用权利要求1-14中任一项的芯片装置或权利要求15-16中任一项的仪器检测样本中的核酸的方法,所述检测方法包括以下步骤:提供权利要求1-14中任一项的芯片装置或具有所述芯片装置的仪器,所述芯片装置具有基板和活塞式容器,所述活塞式容器之间通过微流体通道连通,其中,所述活塞式容器包括腔体和位于腔体内的活塞,腔体底部具有与所述微流体通道连通的开口,所述芯片装置还具有位于容器之间的活塞阀,用于控制相互连通的容器之间的流体连通,所述活塞阀包括阀腔体和位于阀腔体内的阀活塞,其中,所述芯片装置包括:样品接收模块;样品裂解和核酸提取模块,可用于对样品进行裂解反应和/或核酸提取反应,从样品中获得纯化的核酸;所述样品裂解和提取模块中具有样品裂解模块和/或核酸提取模块,任选的,所述核酸提取模块包括核酸结合单元、核酸清洗单元和核酸洗脱单元;和核酸扩增模块,用于将核酸样品分配到多个扩增区容器(例如为扩增反应腔)以及对核酸分子进行扩增和/或检测;核酸扩增模块包括多重扩增区模块和任选的前置扩增区模块,其中,所述仪器任选包括:芯片装置接收和运动控制系统;磁体和控制磁体移动的系统;调节所述活塞阀中的活塞运动控制件的运动的控制机构,所述控制机构包括控制杆和控制杆运动机构,控制杆可进行旋转或上下运动,其中所述控制杆运动机构包括控制所述控制杆上下运动和旋转的部件,例如电机;检测核酸扩增产物的信号检测模块,例如为荧光检测系统;对所述芯片的核酸扩增区域进行温控的系统;核酸扩增结果分析和/或输出系统,所述方法任选包括以下步骤:通过所述芯片装置的样品接收模块加入待测样品;通过所述芯片装置的样品裂解和核酸提取模块对样品进行裂解反应和/或核酸提取反应,从样品中获得纯化的核酸;通过所述核酸扩增模块,用于将核酸样品分配到多个扩增区容器以及对核酸分子进行扩增和/或检测。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP22832113.9A EP4365564A1 (en) | 2021-06-30 | 2022-06-29 | Chip device and instrument for nucleic acid detection, and application thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110743068.9 | 2021-06-30 | ||
CN202110743068 | 2021-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023274301A1 true WO2023274301A1 (zh) | 2023-01-05 |
Family
ID=84691452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/102391 WO2023274301A1 (zh) | 2021-06-30 | 2022-06-29 | 检测核酸的芯片装置和仪器及其应用 |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4365564A1 (zh) |
CN (2) | CN219792985U (zh) |
WO (1) | WO2023274301A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117264749A (zh) * | 2023-11-23 | 2023-12-22 | 中国科学院空天信息创新研究院 | 多指标检测装置及其使用方法 |
CN117282483A (zh) * | 2023-11-23 | 2023-12-26 | 中国科学院空天信息创新研究院 | 分析试管和分析装置 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060222569A1 (en) * | 2003-04-25 | 2006-10-05 | Roland Barten | Device and method for the preparation of analyte comprising liquids |
CN105189784A (zh) * | 2013-05-07 | 2015-12-23 | 精密公司 | 用于制备和分析核酸的装置 |
CN107541452A (zh) * | 2017-09-20 | 2018-01-05 | 清华大学 | 一种微流控芯片及芯片组件 |
US20190212233A1 (en) * | 2016-11-29 | 2019-07-11 | Stevan Jovanovich | Method and apparatus for processing tissue samples |
CN110257245A (zh) * | 2019-07-16 | 2019-09-20 | 东莞博识生物科技有限公司 | 核酸检测试剂卡 |
CN111647498A (zh) * | 2020-05-25 | 2020-09-11 | 清华大学 | 一种一体化自助式核酸检测装置及其使用方法 |
CN112871230A (zh) * | 2021-03-05 | 2021-06-01 | 江苏汇先医药技术有限公司 | 一种核酸扩增用的立式微流控芯片 |
-
2022
- 2022-06-29 CN CN202221652666.1U patent/CN219792985U/zh active Active
- 2022-06-29 WO PCT/CN2022/102391 patent/WO2023274301A1/zh active Application Filing
- 2022-06-29 CN CN202210748579.4A patent/CN115537317A/zh active Pending
- 2022-06-29 EP EP22832113.9A patent/EP4365564A1/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060222569A1 (en) * | 2003-04-25 | 2006-10-05 | Roland Barten | Device and method for the preparation of analyte comprising liquids |
CN105189784A (zh) * | 2013-05-07 | 2015-12-23 | 精密公司 | 用于制备和分析核酸的装置 |
US20190212233A1 (en) * | 2016-11-29 | 2019-07-11 | Stevan Jovanovich | Method and apparatus for processing tissue samples |
CN107541452A (zh) * | 2017-09-20 | 2018-01-05 | 清华大学 | 一种微流控芯片及芯片组件 |
CN110257245A (zh) * | 2019-07-16 | 2019-09-20 | 东莞博识生物科技有限公司 | 核酸检测试剂卡 |
CN111647498A (zh) * | 2020-05-25 | 2020-09-11 | 清华大学 | 一种一体化自助式核酸检测装置及其使用方法 |
CN112871230A (zh) * | 2021-03-05 | 2021-06-01 | 江苏汇先医药技术有限公司 | 一种核酸扩增用的立式微流控芯片 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117264749A (zh) * | 2023-11-23 | 2023-12-22 | 中国科学院空天信息创新研究院 | 多指标检测装置及其使用方法 |
CN117282483A (zh) * | 2023-11-23 | 2023-12-26 | 中国科学院空天信息创新研究院 | 分析试管和分析装置 |
CN117264749B (zh) * | 2023-11-23 | 2024-02-02 | 中国科学院空天信息创新研究院 | 多指标检测装置及其使用方法 |
CN117282483B (zh) * | 2023-11-23 | 2024-02-02 | 中国科学院空天信息创新研究院 | 分析试管和分析装置 |
Also Published As
Publication number | Publication date |
---|---|
EP4365564A1 (en) | 2024-05-08 |
CN115537317A (zh) | 2022-12-30 |
CN219792985U (zh) | 2023-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yin et al. | Integrated microfluidic systems with sample preparation and nucleic acid amplification | |
US8748165B2 (en) | Methods for generating short tandem repeat (STR) profiles | |
US20220034770A1 (en) | Sample preparation for difficult sample types | |
WO2023274301A1 (zh) | 检测核酸的芯片装置和仪器及其应用 | |
JP5782384B2 (ja) | 未処理試料から核酸を単離するための自己完結型装置および精製方法 | |
Chen et al. | An integrated, self-contained microfluidic cassette for isolation, amplification, and detection of nucleic acids | |
Sauer-Budge et al. | Low cost and manufacturable complete microTAS for detecting bacteria | |
US20050221281A1 (en) | Self-contained microfluidic biochip and apparatus | |
EP2261650A2 (en) | Microfluidic devices | |
KR20120051709A (ko) | 미세유체 장치 및 이의 용도 | |
EP4170008A1 (en) | Sample processing and detection apparatus and application thereof | |
US20180369819A1 (en) | Multi-functional Microfluidics Device for Biological Sample Screening | |
AU2017235971A1 (en) | Nucleic Acid Purification | |
Han et al. | Disposable, pressure-driven, and self-contained cartridge with pre-stored reagents for automated nucleic acid extraction | |
US8808643B1 (en) | Fluidics platform and method for sample preparation and analysis | |
WO2023186159A1 (zh) | 快速检测核酸的芯片装置和仪器以及其应用 | |
Tupik et al. | Helicase-Dependent Isothermal Amplification of Nucleic Acids on Microfluidic Array Chip |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22832113 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022832113 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 18574796 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2022832113 Country of ref document: EP Effective date: 20240130 |